These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17426837)

  • 1. Blood serum DNA in patients with rheumatoid arthritis is considerably enriched with fragments of ribosomal repeats containing immunostimulatory CpG-motifs.
    Veiko NN; Shubaeva NO; Ivanova SM; Speranskii AI; Lyapunova NA; Spitkovskii DM
    Bull Exp Biol Med; 2006 Sep; 142(3):313-6. PubMed ID: 17426837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of Toll-like Receptor 9 Responses through Synthetic Immunostimulatory Motifs of DNA.
    Agrawal S; Kandimalla ER
    Ann N Y Acad Sci; 2003 Dec; 1002():30-42. PubMed ID: 14751820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Enrichment of extracellular DNA from the cultivation medium of human peripheral blood mononuclears with genomic CpG rich fragments results in increased cell production of IL-6 and TNF-a via activation of the NF-kB signaling pathway].
    Speranskii AI; Kostyuk SV; Kalashnikova EA; Veiko NN
    Biomed Khim; 2016 Mar; 62(3):331-40. PubMed ID: 27420628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for Toll in autoimmunity.
    Krieg AM
    Nat Immunol; 2002 May; 3(5):423-4. PubMed ID: 11976718
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of immunostimulatory DNA and TLR9 in gene therapy.
    Yasuda K; Wagner H; Takakura Y
    Crit Rev Ther Drug Carrier Syst; 2006; 23(2):89-110. PubMed ID: 16952273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to CpG DNA-induced autoimmunity through tolerogenic B cell antigen receptor ERK signaling.
    Rui L; Vinuesa CG; Blasioli J; Goodnow CC
    Nat Immunol; 2003 Jun; 4(6):594-600. PubMed ID: 12740574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition.
    Bauer S; Kirschning CJ; Häcker H; Redecke V; Hausmann S; Akira S; Wagner H; Lipford GB
    Proc Natl Acad Sci U S A; 2001 Jul; 98(16):9237-42. PubMed ID: 11470918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of immunostimulatory CpG-rich sequences from different Bifidobacterium species.
    Ménard O; Gafa V; Kapel N; Rodriguez B; Butel MJ; Waligora-Dupriet AJ
    Appl Environ Microbiol; 2010 May; 76(9):2846-55. PubMed ID: 20208019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis of CpG and inhibitory DNA recognition by Toll-like receptor 9.
    Ohto U; Shibata T; Tanji H; Ishida H; Krayukhina E; Uchiyama S; Miyake K; Shimizu T
    Nature; 2015 Apr; 520(7549):702-5. PubMed ID: 25686612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLR9 signals after translocating from the ER to CpG DNA in the lysosome.
    Latz E; Schoenemeyer A; Visintin A; Fitzgerald KA; Monks BG; Knetter CF; Lien E; Nilsen NJ; Espevik T; Golenbock DT
    Nat Immunol; 2004 Feb; 5(2):190-8. PubMed ID: 14716310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunophysiological impact of bacterial CpG DNA on the gut.
    Watson JL; McKay DM
    Clin Chim Acta; 2006 Feb; 364(1-2):1-11. PubMed ID: 16153626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in immunostimulatory CpG oligonucleotides.
    Rothenfusser S; Tuma E; Wagner M; Endres S; Hartmann G
    Curr Opin Mol Ther; 2003 Apr; 5(2):98-106. PubMed ID: 12772497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunostimulatory CpG-DNA activates murine microglia.
    Dalpke AH; Schäfer MK; Frey M; Zimmermann S; Tebbe J; Weihe E; Heeg K
    J Immunol; 2002 May; 168(10):4854-63. PubMed ID: 11994434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus.
    Nakano S; Morimoto S; Suzuki J; Nozawa K; Amano H; Tokano Y; Takasaki Y
    Rheumatology (Oxford); 2008 Feb; 47(2):145-9. PubMed ID: 18160420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CpG motif-independent activation of TLR9 upon endosomal translocation of "natural" phosphodiester DNA.
    Yasuda K; Rutz M; Schlatter B; Metzger J; Luppa PB; Schmitz F; Haas T; Heit A; Bauer S; Wagner H
    Eur J Immunol; 2006 Feb; 36(2):431-6. PubMed ID: 16421948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune mechanisms and therapeutic potential of CpG oligodeoxynucleotides.
    Wilson HL; Dar A; Napper SK; Marianela Lopez A; Babiuk LA; Mutwiri GK
    Int Rev Immunol; 2006; 25(3-4):183-213. PubMed ID: 16818371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased suppression of immune stimulatory CpG motifs in plant DNA.
    Wang Y; Zhou J; Liu B
    Immunol Lett; 2007 Dec; 114(2):73-80. PubMed ID: 17889375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CpG-containing oligodeoxynucleotides act through TLR9 to enhance the NK cell cytokine response to antibody-coated tumor cells.
    Roda JM; Parihar R; Carson WE
    J Immunol; 2005 Aug; 175(3):1619-27. PubMed ID: 16034101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunostimulatory DNA as a vaccine adjuvant.
    Higgins D; Marshall JD; Traquina P; Van Nest G; Livingston BD
    Expert Rev Vaccines; 2007 Oct; 6(5):747-59. PubMed ID: 17931155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner.
    Rutz M; Metzger J; Gellert T; Luppa P; Lipford GB; Wagner H; Bauer S
    Eur J Immunol; 2004 Sep; 34(9):2541-50. PubMed ID: 15307186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.